Cargando…

Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia

BACKGROUND: AML is a heterogeneous disease, and despite intensive therapy, recurrence is still high in AML patients who achieve the criterion for cytomorphologic remission (residual tumor burden [measurable residual disease, MRD]<5%). This study aimed to develop a targeted next-generation sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Ju, Jang, Ji Eun, Lee, Hyeon Ah, Park, Mi Ri, Kook, Hye Won, Lee, Seung-Tae, Choi, Jong Rak, Min, Yoo Hong, Shin, Saeam, Cheong, June-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989530/ https://www.ncbi.nlm.nih.gov/pubmed/36843401 http://dx.doi.org/10.3343/alm.2023.43.4.328

Ejemplares similares

Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
por: Ha, Jihye, et al.
Publicado: (2016)

Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
por: Kook, Hye Won, et al.
Publicado: (2022)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
por: Kim, Borahm, et al.
Publicado: (2019)

Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia
por: Shin, Saeam, et al.
Publicado: (2017)

Precision Medicine through Next-Generation Sequencing in Inherited Eye Diseases in a Korean Cohort
por: Moon, Dabin, et al.
Publicado: (2021)

Next-Generation Sequencing in Korean Children With Autism Spectrum Disorder and Comorbid Epilepsy
por: Lee, Junghan, et al.
Publicado: (2020)

Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia
por: Yu, Nae, et al.
Publicado: (2017)

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
por: Kim, TaeHyung, et al.
Publicado: (2020)

Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
por: Park, Hyunsung, et al.
Publicado: (2017)

Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
por: Lee, Hyeonah, et al.
Publicado: (2023)

FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
por: Lee, Jong-Mi, et al.
Publicado: (2022)

FLT3 Internal Tandem Duplication in Patients With Acute Myeloid Leukemia Is Readily Detectable in a Single Next-Generation Sequencing Assay Using the Pindel Algorithm
por: Kim, Borahm, et al.
Publicado: (2019)

All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
por: Kim, Yundeok, et al.
Publicado: (2020)

Diagnostic yield of targeted next-generation sequencing for pediatric hereditary hemolytic anemia
por: Choi, Yu Jeong, et al.
Publicado: (2023)

Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
por: Levine, Ross L., et al.
Publicado: (2019)

Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia
por: Kim, Seon Young, et al.
Publicado: (2023)

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2022)

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
por: Hwang, Doh Yu, et al.
Publicado: (2020)

Genetic spectrum and characteristics of autosomal optic neuropathy in Korean: Use of next-generation sequencing in suspected hereditary optic atrophy
por: Seo, Yuri, et al.
Publicado: (2022)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)

Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings
por: Ishida, Hisashi, et al.
Publicado: (2020)

Rare Gene Rearrangement t(11;22)(q23;q13)/KMT2A-EP300 in Therapy-related Acute Myeloid Leukemia: A Case Report
por: Kim, Seo Wan, et al.
Publicado: (2022)

t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016)

Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016)

Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells
por: Kim, Soo-Jeong, et al.
Publicado: (2012)

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
por: Patkar, Nikhil, et al.
Publicado: (2021)

Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Kim, Hee-Je, et al.
Publicado: (2021)

Next‐generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia
por: Yun, Jae Won, et al.
Publicado: (2019)

Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis
por: Kim, Borahm, et al.
Publicado: (2019)

Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing
por: Salipante, Stephen J., et al.
Publicado: (2014)

An 18.3-Mb Duplication on Chromosome 14q With Multiple Cardiac Anomalies and Clubfoot Was Identified by Microarray Analysis
por: Yoon, Jihoon G., et al.
Publicado: (2016)

Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
por: Chen, Man, et al.
Publicado: (2023)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
por: Jang, Ji Eun, et al.
Publicado: (2023)

Measurable residual disease in chronic myeloid leukemia
por: Branford, Susan, et al.
Publicado: (2022)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations
por: Choi, Yoon Ji, et al.
Publicado: (2022)

PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells
por: Jang, Ji Eun, et al.
Publicado: (2020)

A case of synchronous multiple myeloma and chronic myeloid leukemia
por: Lee, Ji-Young, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1lentofovji3djmbjemimqpr2r